- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
8 result(s) found for: PMDD.
Displaying page 1 of 1.
| EudraCT Number: 2012-004081-18 | Sponsor Protocol Number: UM104 | Start Date*: 2012-12-06 |
| Sponsor Name:Umecrine Mood AB | ||
| Full Title: A randomized, double-blind, placebo-controlled parallel-group study on safety, tolerability, pharmacokinetics and pharmacodynamics of UC1010 administered subcutaneously, single-dosing in healthy wo... | ||
| Medical condition: Premenstrual Dysphoric Disorder (PMDD) | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000822-37 | Sponsor Protocol Number: UM203 | Start Date*: 2017-10-30 | |||||||||||
| Sponsor Name:Asarina Pharma | |||||||||||||
| Full Title: A phase II, randomised, double-blind, placebo-controlled, parallel-group, multi-centre study investigating efficacy and safety of Sepranolone (UC1010) in patients with PMDD | |||||||||||||
| Medical condition: Premenstrual dysphoric disorder (PMDD) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: GB (Completed) DE (Completed) SE (Completed) PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-002540-94 | Sponsor Protocol Number: UNC4022 | Start Date*: 2004-11-25 |
| Sponsor Name:Norrlands university hospital | ||
| Full Title: Effects of allopregnanolone in women with PMDD, depression, PCOS och oral contraceptives | ||
| Medical condition: PMDD (premenstrual dysphoric disorder) includes depressed mood and anxiety but occurs only during the late phase of the menstrual cycle. Major depression are more common in women and especially pos... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-001217-25 | Sponsor Protocol Number: 2016-001217-25 | Start Date*: 2016-09-07 |
| Sponsor Name:Uppsala University | ||
| Full Title: Emotion, Serotonin and Premenstrual Dysphoric Disorder (EmSeP) | ||
| Medical condition: Premenstrual Dysphoric Disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-005173-27 | Sponsor Protocol Number: 0858A4-318-WW | Start Date*: 2005-10-21 |
| Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical Research and Development | ||
| Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A COMBINATION OF LEVONORGESTREL AND ETHINYL ESTRADIOL IN A CONTINUOUS DAILY REGIMEN IN SUBJECTS WITH PREMENSTRUAL DYSPHORIC DISO... | ||
| Medical condition: Premenstrual dysphoric disorder (PMDD) affects 3% to 5% of menstruating women. PMDD is defined by markedly depressed mood, anxiety, and/or affective lability during the last week of the late lutea... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (Completed) FI (Completed) SE (Completed) DK (Completed) DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-001719-19 | Sponsor Protocol Number: 2016:1 | Start Date*: 2016-07-25 |
| Sponsor Name:Uppsala University | ||
| Full Title: Selecitve progesterone receptor modulators for treatment of premenstrual dysphoric disorder. A randomized, double-blind, placebo controlled study. | ||
| Medical condition: Premenstrual dysphoric disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000309-60 | Sponsor Protocol Number: 120101 | Start Date*: 2016-03-30 | |||||||||||
| Sponsor Name:Göteborgs universitet | |||||||||||||
| Full Title: Biochemical and neuropsychological effects on Premenstrual Dysphoric Disorder after acute administration of escitalopram | |||||||||||||
| Medical condition: Premenstrual Dysphoric Disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: SE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-000944-98 | Sponsor Protocol Number: UNC4024 | Start Date*: 2005-05-02 |
| Sponsor Name:Norlands University Hospital | ||
| Full Title: FARMAKOKINETISKA EGENSKAPER HOS ISOALLOPREGNANOLON OCH ANTAGONISM AV ALLOPREGNANOLONS SEDERINGS EFFEKT HOS KVINNOR. Pharmacokinetic properties of isoallopregnanolone and antagonism of allopregnano... | ||
| Medical condition: Premenstrual Dysphoric Disorder (PMDD) / Severe Premenstrual Syndrome (PMS) | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
